These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship. Karino S; Kaye KS; Navalkele B; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Pogue JM Antimicrob Agents Chemother; 2016 Jun; 60(6):3743-50. PubMed ID: 27067325 [TBL] [Abstract][Full Text] [Related]
3. Piperacillin/tazobactam-induced myoclonic jerks in a man with chronic renal failure. Man BL; Fu YP BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25956160 [No Abstract] [Full Text] [Related]
4. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Gomes DM; Smotherman C; Birch A; Dupree L; Della Vecchia BJ; Kraemer DF; Jankowski CA Pharmacotherapy; 2014 Jul; 34(7):662-9. PubMed ID: 24753221 [TBL] [Abstract][Full Text] [Related]
6. Top Guns: The "Maverick" and "Goose" of Empiric Therapy. Davies SW; Efird JT; Guidry CA; Dietch ZC; Willis RN; Shah PM; Sawyer RG Surg Infect (Larchmt); 2016 Feb; 17(1):38-47. PubMed ID: 26484854 [TBL] [Abstract][Full Text] [Related]
7. Acute localized exanthematous pustulosis on inguinal area secondary to piperacillin/tazobactam. Huilaja L; Kallioinen M; Soronen M; Riekki R; Tasanen K Acta Derm Venereol; 2014 Jan; 94(1):106-7. PubMed ID: 23817479 [No Abstract] [Full Text] [Related]
8. Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin-tazobactam as compared with cefepime. Moenster RP; Linneman TW; Finnegan PM; Hand S; Thomas Z; McDonald JR Clin Microbiol Infect; 2014 Jun; 20(6):O384-9. PubMed ID: 24118354 [TBL] [Abstract][Full Text] [Related]
9. Dress induced by piperacillin-tazobactam in a child. González Díaz C; González Hermosa A; García-Lirio E; Martínez-Aranguren R; Gamboa Setien P J Allergy Clin Immunol Pract; 2015; 3(4):615-7. PubMed ID: 25869582 [No Abstract] [Full Text] [Related]
11. Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do? Watkins RR; Deresinski S Clin Infect Dis; 2017 Nov; 65(12):2137-2143. PubMed ID: 29020249 [TBL] [Abstract][Full Text] [Related]
12. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit. Boyce K; Brar H; Stabler SN J Clin Pharm Ther; 2016 Dec; 41(6):730-732. PubMed ID: 27670947 [TBL] [Abstract][Full Text] [Related]
13. Drug fever induced by piperacillin/tazobactam in an elderly patient with underlying human immunodeficiency virus (HIV) infection. Swe T; Ali M; Naing AT BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27440850 [TBL] [Abstract][Full Text] [Related]
14. Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children. Patel A; Mao KR; McNeil JC; Kaplan SL; Vallejo JG Pediatr Infect Dis J; 2015 Aug; 34(8):849-50. PubMed ID: 25961892 [TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury risk associated with piperacillin/tazobactam compared with cefepime during vancomycin therapy in hospitalised patients: a cohort study stratified by baseline kidney function. Jeon N; Staley B; Klinker KP; Hincapie Castillo J; Winterstein AG Int J Antimicrob Agents; 2017 Jul; 50(1):63-67. PubMed ID: 28522340 [TBL] [Abstract][Full Text] [Related]
16. A possible role of IL-23-producing cells in a patient with psoriasiform drug eruption due to tazobactam and piperacillin hydrate: a case study and literature review. Saito-Sasaki N; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Okada E; Nakamura M Eur J Dermatol; 2017 Feb; 27(1):88-89. PubMed ID: 27748262 [No Abstract] [Full Text] [Related]
18. Piperacillin-Tazobactam Induced Interstitial Nephritis, Hepatitis and Serum Sckness-Like Illness. Kraleti S; Khatri N; Jarrett D J Ark Med Soc; 2016 Jun; 112(14):278-80. PubMed ID: 27434982 [TBL] [Abstract][Full Text] [Related]
19. Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure. Lorenz MA; Moenster RP; Linneman TW J Med Microbiol; 2016 Feb; 65(2):195-199. PubMed ID: 26690496 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the incidence of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or with meropenem. Al Yami MS J Infect Public Health; 2017; 10(6):770-773. PubMed ID: 28209320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]